CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Proterion Corporation is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Proterion Corporation
1 Possumtown Rd
Phone: (908) 560-8550p:908 560-8550 PISCATAWAY, NJ  08854-2103  United States Fax: (302) 655-5049f:302 655-5049

This company ceased filing statements with the SEC on 3/29/2004.
This company is no longer actively traded on any major stock exchange.

Business Summary
Proterion Corporation designs, manufactures, markets and services computer-controlled life sciences instruments for particle sizing and biomolecular characterization for use in material and product research and development. Dynamic Light Scattering systems are used to determine the size of molecules. The instruments in which the Company specializes are designed specifically for protein molecules. Circular Dichroism Spectrometers determine secondary protein structure and can predict how a protein will react under different conditions. Automated Titrating Differential/Ratio Spectrofluorometers use fluorescence to determine protein behavior. Spectrophotometers measures how light is absorbed by a protein and can determine size and the conformation of the protein molecule. Plasmon-Waveguide Resonance Spectroscopy instruments simplify the process of identifying therapeutic proteins and drugs, and simulate the way in which proteins and drugs interact with membranes and each other.
(Source: 10-K)

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
9/30/200312/31/2002YesYes---

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Chairman of the Board, Chief Executive Officer Robert M.Castello 67 3/6/2000 3/6/2000
Chief Financial Officer StephenObeda 4/25/2003 4/25/2003
President, Chief Operating Officer Paul S.Mangano 50 8/27/2001 8/27/2001
7 additional Officers and Directors records available in full report.

General Information
Number of Employees: 38 (As of 12/31/2002)
Outstanding Shares: 26,032,000 (As of 9/30/2003)
Shareholders: 172
Stock Exchange: OTC
Federal Tax Id: 610708419
Fax Number: (302) 655-5049


Copyright © 2023 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Saturday, July 22, 2023